(Q45874878)

17 December 2017

title

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells (English)

1 reference

17 December 2017

Human Induced Pluripotent Stem Cells

main subject

1 reference

9

1 reference

17 December 2017

author name string

K M Silk

1

1 reference

17 December 2017

J D Silk

2

1 reference

17 December 2017

N Ichiryu

3

1 reference

17 December 2017

T J Davies

4

1 reference

17 December 2017

K F Nolan

5

1 reference

17 December 2017

A J Leishman

6

1 reference

17 December 2017

L Carpenter

7

1 reference

17 December 2017

S M Watt

8

1 reference

17 December 2017

P J Fairchild

10

1 reference

17 December 2017

publication date

10 November 2011

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

19

1 reference

17 December 2017

issue

10

1 reference

17 December 2017

page(s)

1035-1040

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2011.177

exact match

0 references

cites work

Designing vaccines based on biology of human dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Presentation of tumour antigens by dendritic cells and challenges faced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Found in translation: the human equivalent of mouse CD8+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Reprogramming of human somatic cells to pluripotency with defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Human induced pluripotent stem cells are capable of B-cell lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

CpG-DNA aided cross-presentation of soluble antigens by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Cancer prevention with semi-allogeneic ES cell-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

The allogeneic response and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Molecular antagonism and plasticity of regulatory and inflammatory T cell programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

IL-6: regulator of Treg/Th17 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

The promise of human induced pluripotent stem cells for research and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

A needle in the 'cancer vaccine' haystack

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.177

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.177

1 reference

17 December 2017

Dimensions Publication ID

1040049242

0 references

1 reference

17 December 2017